GRI Bio, Inc. GRI

2.05 (0.04) (1.91%) as of 25 Sep
Market cap
$4.6M
P/E
0.0×
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17
P/E ratio
— — — — — 0.00 — — —
P/S ratio
— — — — — 0.00 — — —
P/FCF ratio
— — — — — 0.00 — — —
P/Operating CF
— — — — — (54,496,333.59) — — —
P/B ratio
— — — — — 0.00 — — —
Price to Tangible BV
— — — — — 0.00 — — —
EV/Sales
— — — — — 0.00 — — —
EV/EBITDA
— — — — — 0.00 — — —
EV/Operating CF
— — — — — (11,881,553.55) — — —
EV/FCF
— — — — — (11,875,144.94) — — —
Quick Ratio
3.11 3.07 0.67 0.00 3.07 0.05 4.73 1.26 —
Current Ratio
3.25 3.43 1.09 0.16 3.32 0.30 4.85 1.31 —
Net Debt/EBITDA
0.69 0.61 0.19 0.00 0.81 0.02 1.21 0.14 —
Debt/Assets
0.00% 0.00% 0.00% 0.00% 0.86% 1.47% 5.94% 0.00% 0.00%
Debt/Equity
0.00 0.00 0.00 0.00 0.01 (0.01) 0.08 0.00 —
Asset Turnover
0.00 0.00 0.00 0.00 0.00 0.04 0.00 0.00 —
Operating CF/Net income
0.85 0.85 0.69 0.34 0.89 0.77 0.83 0.55 —
Capex/Depreciation
(0.75) 0.00 0.00 (0.01) 0.00 (0.03) 0.00 0.00 —
Interest Coverage
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 —
ROE
(238.17%) (471.59%) 1,908.78% (153.45%) (426.35%) (547.95%) (205.77%) (256.19%) —
ROA
(166.00%) (232.73%) (780.89%) (73.80%) (200.28%) (184.36%) (140.95%) (1,349.37%) —
ROIC
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% —
Return on Tangible Assets
(200.87%) (254.03%) (5,321.22%) 191.72% (157.95%) 311.30% (111.20%) (2,820.54%) —
Average Days of Receivables
— — — — — 0.00 — — —
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 3,707.00% 0.00% 0.00% —
Selling, General and Administrative Expense of Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 1,181.00% 0.00% 0.00% —
Intangible Assets out of Total Assets
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Share Based Compensation of Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 154.00% 0.00% — —
Graham Net Nets
— — — — — 0.00 — — —
Graham Number
— — — — — 2.79 — — —
Earnings Yield
— — — — — 0.00% — — —
Free Cash Flow Yield
— — — — — 0.00% — — —
Revenue per Share
0.00 0.00 0.00 0.00 0.00 0.02 0.00 0.00 —
Operating CF per Share
(103.73) (1,324.77) (89,900.00) 0.00 (1.27) (0.82) (0.81) (10.44) —
Capex per Share
(0.03) 0.00 (80.00) 0.00 0.00 0.00 0.00 0.00 —
Free Cash Flow per Share
(103.76) (1,324.77) (89,980.00) 0.00 (1.27) (0.82) (0.81) (10.44) —
Cash per Share
83.80 773.54 18,080.00 0.00 1.15 0.02 1.08 2.70 —
Shareholders Equity per Share
61.18 620.31 2,590.00 0.00 0.89 (0.32) 0.91 0.67 —
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 —
Book value per Share
61.18 620.31 2,590.00 0.00 0.89 (0.32) 0.91 0.67 —
Free Cash Flow
(10.19) (8.61) (9.00) (1.09) (8.31) (3.71) (2.88) (2.37) —
Working Capital
5.95 3.98 0.24 (1.68) 5.68 (1.55) 3.11 0.15 —
Capital Expenditures
0.00 — (0.01) 0.00 — 0.00 — 0.00 —
Net Current Asset Value
5.93 3.91 0.24 (1.70) 5.61 (1.73) 2.86 0.15 —
EV/EBIT
— — — — — 0.00 — — —
Capex to Sales
0.00 — 0.00 0.00 — 0.02 — — —
Net Profit Margin
0.00% 0.00% 0.00% 0.00% 0.00% (4,822.00%) 0.00% 0.00% —
Price to Operating Income
— — — — — 0.00 — — —
Other line items
Depreciation/Fixed assets
1.33 1.00 263.50 55.00 0.51 37.00 206.00 0.38 —
Cash ROIC
(71.57%) (95.09%) (435.32%) 67.39% (63.57%) 278.59% (39.58%) (309.90%) —
Accounts Receivable Turnover
— — — — — 0.00 — — —
Accounts Payable Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 —
Inventory Turnover
— — — 0.00 0.00 — 0.00 0.00 —
Average Days of Payables
0.00 0.00 0.00 0.00 0.00 0.00 0.00 174,348.33 —
Days of Inventory on Hand
— — — 0.00 0.00 — 0.00 0.00 —
Average Payables
1.37 1.15 1.35 1.11 1.07 0.74 0.27 0.27 —
Average Assets
7.20 4.35 1.67 4.36 4.65 2.62 2.46 0.32 —
Average Common Equity
5.02 2.15 (0.68) 2.10 2.18 0.88 1.68 1.68 —

Fold the line items

Columns are period end dates